News

Video

Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’

Author(s):

A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.

A diagnosis of chromic myeloid leukemia (CML) can lead to a “long treatment journey,” but there are organizations and resources that can help with some of the common issues patients and their loved ones face, said Claire Saxton, executive vice president of Insights and Impact at Cancer Support Community.

In an interview with CURE® at the 2024 American Society of Clinical Oncology Annual Meeting, Saxton discussed where patients with CML and caregivers can look for help. These organizations can offer services such as financial counseling, support groups and mental health professionals.

“This is a long treatment journey, and there is a huge impact on your life and your family’s life, and also on your mental health,” Saxton said in the interview.

READ MORE: Mending the Mind After Cancer

Transcript:

This is a long treatment journey, and there is a huge impact on your life on your family's life and also on your mental health.

Reach out for resources. It can be hard to find them initially, but there are a number of patient advocacy groups like Cancer Support Community, [Leukemia & Lymphoma Society], CML Buster [Foundation] who are here and ready to help with financial counsellors, support groups, access to mental health professionals, because those are the kinds of things that are going to help give you the support that you need to get through this long term.

Editor's Note: This program was made possible with support from Novartis Pharmaceuticals.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of woman, with text.
Image of woman with text.
Image of man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Image of Dr. Zhaoming Wang with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Woman with text.
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
Related Content